254 related articles for article (PubMed ID: 11127820)
21. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
[TBL] [Abstract][Full Text] [Related]
22. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
[TBL] [Abstract][Full Text] [Related]
23. Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
Davis JR; Mossalam M; Lim CS
Mol Pharm; 2013 Apr; 10(4):1340-9. PubMed ID: 23398638
[TBL] [Abstract][Full Text] [Related]
24. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
Zhu Q; Yao J; Wani G; Wani MA; Wani AA
J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
26. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.
Zaika A; Marchenko N; Moll UM
J Biol Chem; 1999 Sep; 274(39):27474-80. PubMed ID: 10488081
[TBL] [Abstract][Full Text] [Related]
28. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
Gu J; Nie L; Wiederschain D; Yuan ZM
Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide induces phosphorylation of p53 and impairs nuclear export.
Schneiderhan N; Budde A; Zhang Y; Brüne B
Oncogene; 2003 May; 22(19):2857-68. PubMed ID: 12771937
[TBL] [Abstract][Full Text] [Related]
30. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage.
Shirangi TR; Zaika A; Moll UM
FASEB J; 2002 Mar; 16(3):420-2. PubMed ID: 11790725
[TBL] [Abstract][Full Text] [Related]
31. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
32. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
33. Critical contribution of the MDM2 acidic domain to p53 ubiquitination.
Kawai H; Wiederschain D; Yuan ZM
Mol Cell Biol; 2003 Jul; 23(14):4939-47. PubMed ID: 12832479
[TBL] [Abstract][Full Text] [Related]
34. Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein.
Menéndez S; Higgins M; Berkson RG; Edling C; Lane DP; Laín S
Br J Cancer; 2003 Feb; 88(4):636-43. PubMed ID: 12592381
[TBL] [Abstract][Full Text] [Related]
35. MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.
Rodriguez-Lopez AM; Xenaki D; Eden TO; Hickman JA; Chresta CM
Mol Pharmacol; 2001 Jan; 59(1):135-43. PubMed ID: 11125034
[TBL] [Abstract][Full Text] [Related]
36. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.
Zhang Y; Xiong Y
Science; 2001 Jun; 292(5523):1910-5. PubMed ID: 11397945
[TBL] [Abstract][Full Text] [Related]
37. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639
[TBL] [Abstract][Full Text] [Related]
38. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents.
Inoue T; Geyer RK; Yu ZK; Maki CG
FEBS Lett; 2001 Feb; 490(3):196-201. PubMed ID: 11223035
[TBL] [Abstract][Full Text] [Related]
40. Regulation of p53 by Mdm2: fate is in the numbers.
Shmueli A; Oren M
Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
